Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/422"

Predicate	Value (sorted: default)
rdfs:label	"evidence_1544"
rdf:type	?:Evidence ?:Item
?:Evidence_enzyme_system	"none_assigned"
?:Evidence_type	?:Non_Tracable_Statement
?:Evidence_value	"0.00005278"
?:content	"The FDA, in it most recent guidance document, recommends this as a chemical inhibitor of CYP2B6 for in vitro experiments at a K_i of 0.2micM. See Table 2, p. 28 0.2.micM/L X 1M/10^6micM X 263.876g/M = 0.00005278g/L"
dc:creator	"boycer"
dc:date	"06/30/2009 14:20:44"
rdfs:seeAlso	?:FDA-Guidance-Drug-Interaction-Studies%E2%80%93Study%20Design-Data-Analysis-and-Implications-2006.pdf

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ ticlopidine_inhibition_constant_cyp2b6, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1544 }

Context graph